Your browser doesn't support javascript.
loading
Coexistence of Charcot-Marie-Tooth 1A and nondystrophic myotonia due to PMP22 duplication and SCN4A pathogenic variants: a case report.
Nan, Haitian; Wu, Yunqing; Cui, Shilei; Sun, Houliang; Wang, Jiawei; Li, Ying; Meng, Lingchao; Nagasaka, Takamura; Wu, Liyong.
Afiliação
  • Nan H; Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China.
  • Wu Y; Department of Neurology, Beijing Tongren Hospital, Capital Medical University, Beijing, China.
  • Cui S; Department of Neurology, Beijing Tongren Hospital, Capital Medical University, Beijing, China.
  • Sun H; Department of Neurology, Beijing Tongren Hospital, Capital Medical University, Beijing, China.
  • Wang J; Department of Neurology, Beijing Tongren Hospital, Capital Medical University, Beijing, China.
  • Li Y; Department of Neurology, Peking University First Hospital, Beijing, China.
  • Meng L; Department of Neurology, Peking University First Hospital, Beijing, China.
  • Nagasaka T; Department of Neurology, University of Yamanashi, 1110 Shimokato, Chuo-city, Yamanashi, 409-3898, Japan.
  • Wu L; Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China. wmywly@hotmail.com.
BMC Neurol ; 22(1): 17, 2022 Jan 07.
Article em En | MEDLINE | ID: mdl-34996390
ABSTRACT

BACKGROUND:

Charcot-Marie-Tooth disease (CMT) is a genetically heterogeneous hereditary neuropathy, and CMT1A is the most common form; it is caused by a duplication of the peripheral myelin protein 22 (PMP22) gene. Mutations in the transient sodium channel Nav1.4 alpha subunit (SCN4A) gene underlie a diverse group of dominantly inherited nondystrophic myotonias that run the spectrum from subclinical myopathy to severe muscle stiffness, disabling weakness, or frank episodes of paralysis. CASE PRESENTATION We describe a Chinese family affected by both CMT1A and myotonia with concomitant alterations in both the PMP22 and SCN4A genes. In this family, the affected proband inherited the disease from his father in an autosomal dominant manner. Genetic analysis confirmed duplication of the PMP22 gene and a missense c.3917G > C (p. Gly1306Ala) mutation in SCN4A in both the proband and his father. The clinical phenotype in the proband showed the combined involvement of skeletal muscle and peripheral nerves. Electromyography showed myopathic changes, including myotonic discharges. MRI revealed the concurrence of neurogenic and myogenic changes in the lower leg muscles. Sural nerve biopsies revealed a chronic demyelinating and remyelinating process with onion bulb formations in the proband. The proband's father presented with confirmed subclinical myopathy, very mild distal atrophy and proximal hypertrophy of the lower leg muscles, pes cavus, and areflexia.

CONCLUSION:

This study reports the coexistence of PMP22 duplication and SCN4A mutation. The presenting features in this family suggested that both neuropathy and myopathy were inherited in an autosomal dominant manner. The proband had a typical phenotype of sodium channel myotonia (SCM) and CMT1A. However, his father with the same mutations presented a much milder clinical phenotype. Our study might expand the genetic and phenotypic spectra of neuromuscular disorders with concomitant mutations.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Artrogripose / Doença de Charcot-Marie-Tooth / Miotonia Limite: Humans / Male Idioma: En Revista: BMC Neurol Assunto da revista: NEUROLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Artrogripose / Doença de Charcot-Marie-Tooth / Miotonia Limite: Humans / Male Idioma: En Revista: BMC Neurol Assunto da revista: NEUROLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China